$CBT Income Statement | Understand Stock

$CBT

$74.02 +$1.14 (1.56%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Sep 30, 2025	FY2024 12 months to Sep 30, 2024	FY2023 12 months to Sep 30, 2023	FY2022 12 months to Sep 30, 2022	FY2021 12 months to Sep 30, 2021
Net sales and other operating revenues
Cost of sales
Gross profit
Selling and administrative expenses
Research and technical expenses
Loss on sale of business and asset impairment charge
Purification Solutions
Total loss on sale of business and asset impairment charge

Loss on sale of business
Income (loss) from operations
Interest and dividend income
Interest expense
Other income (expense)
Income (loss) from operations before income taxes and equity in earnings of affiliated companies
(Provision) benefit for income taxes
Equity in earnings of affiliated companies, net of tax
Net income (loss)
Net income (loss) attributable to noncontrolling interests, net of tax of $12, $11 and $9
Net income (loss) attributable to Cabot Corporation
Weighted-average common shares outstanding:
Basic
Diluted
Earnings (loss) per common share:
Basic
Diluted

Comments